Xiaxia Man Selected Research

Platinum

11/2016

Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaxia Man Research Topics

Disease

6	Neoplasms (Cancer) 06/2022 - 11/2016
2	Triple Negative Breast Neoplasms 01/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2020
1	Pre-Eclampsia (Preeclampsia) 02/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Carcinogenesis 01/2022
1	Chronic Disease (Chronic Diseases) 02/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Leukemia 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Primary Ovarian Insufficiency 12/2019
1	Infertility (Sterility) 12/2019
1	Ischemic Stroke 09/2014
1	Reperfusion Injury 09/2014
1	Ischemia 09/2014
1	Spinal Cord Ischemia 09/2014

Drug/Important Bio-Agent (IBA)

1	CopperIBA 01/2023
1	Disulfiram (Antabuse)FDA Link 01/2023
1	disulfiram-copperIBA 01/2023
1	ChemokinesIBA 06/2022
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Thioguanine (Tioguanine)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019
1	CholesterolIBA 12/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019
1	Estrogens (Estrogen)FDA Link 12/2019
1	PlatinumIBA 11/2016
1	Caspase 3 (Caspase-3)IBA 09/2014
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	ginsenoside RdIBA 09/2014
1	Neuroprotective AgentsIBA 09/2014

Therapy/Procedure

4	Therapeutics 01/2022 - 11/2016
2	Neoadjuvant Therapy 01/2021 - 01/2020
1	Chemoradiotherapy 01/2021
1	Intraperitoneal Injections 09/2014